NeoGenomics, Inc. Stock or Unit Option Plan Expense
NeoGenomics, Inc. (NEO) reported Stock or Unit Option Plan Expense of $566.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-04.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2014-11-04
- NeoGenomics, Inc. stock or unit option plan expense for the quarter ending 2014-09-30 was $320.00K, a 3455.56% increase year-over-year.
- NeoGenomics, Inc. stock or unit option plan expense for the quarter ending 2014-06-30 was $157.00K, a 20.77% increase year-over-year.
- NeoGenomics, Inc. stock or unit option plan expense for the quarter ending 2014-03-31 was $89.00K, a 64.96% decline year-over-year.
- NeoGenomics, Inc. stock or unit option plan expense for the quarter ending 2013-12-31 was $273.00K, a 213.79% increase year-over-year.
- NeoGenomics, Inc. stock or unit option plan expense for fiscal 2013 was $666.00K, a 15.83% increase from fiscal 2012.
- NeoGenomics, Inc. stock or unit option plan expense for fiscal 2012 was $575.00K, a 101.75% increase from fiscal 2011.
- NeoGenomics, Inc. stock or unit option plan expense for fiscal 2011 was $285.00K, a 30.66% decline from fiscal 2010.
- NeoGenomics, Inc. stock or unit option plan expense for fiscal 2010 was $411.00K.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month | Stock or Unit Option Plan Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $320.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $477.00K derived: sum of 2 quarters · filed 2014-11-04 | $566.00K 10-Q · filed 2014-11-04 | $839.00K derived: sum of 4 quarters · filed 2014-11-04 |
| 2014-06-30 | $157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $246.00K 10-Q · filed 2014-07-29 | $519.00K derived: sum of 3 quarters · filed 2014-07-29 | $528.00K derived: sum of 4 quarters · filed 2014-11-04 |
| 2014-03-31 | $89.00K 10-Q · filed 2014-05-12 | $362.00K derived: sum of 2 quarters · filed 2014-05-12 | $371.00K derived: sum of 3 quarters · filed 2014-11-04 | $501.00K derived: sum of 4 quarters · filed 2014-11-04 |
| 2013-12-31 | $273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $282.00K derived: sum of 2 quarters · filed 2014-11-04 | $412.00K derived: sum of 3 quarters · filed 2014-11-04 | $666.00K 10-K · filed 2014-02-24 |
| 2013-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $139.00K derived: sum of 2 quarters · filed 2014-11-04 | $393.00K 10-Q · filed 2014-11-04 | $480.00K derived: sum of 4 quarters · filed 2014-11-04 |
| 2013-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $384.00K 10-Q · filed 2014-07-29 | $471.00K derived: sum of 3 quarters · filed 2014-07-29 | $701.00K derived: sum of 4 quarters · filed 2014-07-29 |
| 2013-03-31 | $254.00K 10-Q · filed 2014-05-12 | $341.00K derived: sum of 2 quarters · filed 2014-05-12 | $571.00K derived: sum of 3 quarters · filed 2014-05-12 | $724.00K derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $317.00K derived: sum of 2 quarters · filed 2014-02-24 | $470.00K derived: sum of 3 quarters · filed 2014-02-24 | $575.00K 10-K · filed 2014-02-24 |
| 2012-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $383.00K derived: sum of 2 quarters · filed 2013-10-30 | $488.00K 10-Q · filed 2013-10-30 | $516.00K derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $258.00K 10-Q · filed 2013-08-02 | $286.00K derived: sum of 3 quarters · filed 2014-02-24 | $364.00K derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $105.00K 10-Q · filed 2013-05-13 | $133.00K derived: sum of 2 quarters · filed 2014-02-24 | $211.00K derived: sum of 3 quarters · filed 2014-02-24 | $297.00K derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $106.00K derived: sum of 2 quarters · filed 2014-02-24 | $192.00K derived: sum of 3 quarters · filed 2014-02-24 | $285.00K 10-K · filed 2014-02-24 |
| 2011-09-30 | $78.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05 | $164.00K derived: sum of 2 quarters · filed 2012-11-05 | $257.00K 10-Q · filed 2012-11-05 | |
| 2011-06-30 | $86.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-15 | $179.00K 10-Q/A · filed 2012-08-15 | ||
| 2011-03-31 | $93.00K 10-Q · filed 2012-05-14 | |||
| 2010-12-31 | $411.00K 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |